54 products
Triple agonist compound.
GLP-1 analog peptide.
Dual GIP/GLP-1 agonist.
HGH fragment peptide.
Mitochondrial peptide.
Metabolic compound.
GLP-1/GCGR agonist.
GLP-1/glucagon agonist.
Adipose targeting peptide.
Growth hormone fragment.
GLP-1 analog high-dose vial.
GLP-1 analog bulk vial.
GIP/GLP-1 agonist bulk vial.
Triple agonist bulk vial.
GLP-1 agonist research peptide.
Long-acting GLP-1 analog.
Exendin-4 based analog.
Non-peptide GLP-1 agonist reference.
Dual GLP-1/glucagon agonist.
Oral GLP-1 agonist reference.
Amylin analog research peptide.
High-dose HGH fragment.
Mitochondrial peptide bulk vial.
NNMT inhibitor bulk vial.
Long-acting amylin analog.
Dual agonist bulk vial.
Cagrilintide + semaglutide research blend.
Dual GLP-1/glucagon receptor agonist — 2026 trending compound.
Oral non-peptide GLP-1 receptor agonist reference.
Long-acting amylin analog reference peptide.
Novel oral GLP-1/amylin dual agonist reference.
High-dose mitochondrial peptide reference.
NNMT inhibitor bulk reference vial.
High-dose triple agonist research vial.
Bulk research vial — dual GIP/GLP-1 agonist.
Bulk research vial — GLP-1 analog.
Triple GLP-1/GIP/glucagon agonist — standard research vial.
Standard dual GIP/GLP-1 agonist research vial.
Mid-dose dual GIP/GLP-1 agonist research vial.
Standard GLP-1 analog research vial.
Bulk GLP-1 analog research vial.
HGH fragment — bulk research vial.
Growth hormone fragment — bulk research vial.
Long-acting amylin analog — standard research vial.
GLP-1/GCGR dual agonist — research reference vial.
Dual GLP-1/glucagon receptor agonist — research vial.
Mitochondrial-derived peptide — standard research vial.
NNMT inhibitor — standard research vial.
Fatty-acid transport research reference.
